UM’s Kelly Sexton: Biotech Industry Continues to Thrive, Find New Solutions

By Nick Manes, Crains Detroit Business

Last May, the University of Michigan inked a $130 million deal with New York City health care investment firm Deerfield Management Co. LP in an effort to ramp up drug commercialization efforts coming out of the Ann Arbor university’s tech transfer office. The deal created Great Lakes Discoveries LLC as the vehicle to drive those developments. The partnership is still in the early stages, said Kelly Sexton, the university’s associate vice president for research, technology transfer and innovation partnerships. But it’s indicative of the need to grow more biotechnology at the university level and figure out ways to bring it to market, Sexton said. . . Download PDF